OA06416A - A method of producing a DNA comprising the genome of the hepatitis B virus and a vector comprising it. - Google Patents
A method of producing a DNA comprising the genome of the hepatitis B virus and a vector comprising it.Info
- Publication number
- OA06416A OA06416A OA56977A OA56977A OA06416A OA 06416 A OA06416 A OA 06416A OA 56977 A OA56977 A OA 56977A OA 56977 A OA56977 A OA 56977A OA 06416 A OA06416 A OA 06416A
- Authority
- OA
- OAPI
- Prior art keywords
- hepatitis
- genome
- virus
- dna
- vector
- Prior art date
Links
- 241000700721 Hepatitis B virus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7835588A FR2444713A1 (en) | 1978-12-18 | 1978-12-18 | PROCESS FOR PRODUCING DNA COMPRISING THE GENOME OF HEPATITIS B VIRUS AND VECTOR COMPRISING SAME |
Publications (1)
Publication Number | Publication Date |
---|---|
OA06416A true OA06416A (en) | 1981-09-30 |
Family
ID=9216265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA56977A OA06416A (en) | 1978-12-18 | 1979-12-18 | A method of producing a DNA comprising the genome of the hepatitis B virus and a vector comprising it. |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE880670A (en) |
CH (1) | CH646456A5 (en) |
DE (1) | DE2950995A1 (en) |
FR (1) | FR2444713A1 (en) |
GB (1) | GB2034323B (en) |
OA (1) | OA06416A (en) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2480779B2 (en) * | 1979-08-30 | 1986-07-18 | Anvar | VECTOR CONTAINING A NUCLEOTIDE SEQUENCE OF THE SURFACE ANTIGEN OF HEPATITIS B VIRUS AND METHOD FOR MANUFACTURING AN IMMUNOGENIC MOLECULE USING THE SAME |
EP0182442B2 (en) * | 1978-12-22 | 1996-04-03 | Biogen, Inc. | Recombinant DNA molecules and their method of production |
LU88257I2 (en) * | 1978-12-22 | 1994-02-03 | ||
US6297355B1 (en) | 1978-12-22 | 2001-10-02 | Biogen, Inc. | Polypeptides displaying HBV antigenicity or hbv antigen specificity |
IE52036B1 (en) * | 1979-05-24 | 1987-05-27 | Univ California | Non-passageable viruses |
US5196194A (en) * | 1979-05-24 | 1993-03-23 | The Regents Of The University Of California | Vaccines containing Hepatitis B S-protein |
US6835557B1 (en) | 1980-01-08 | 2004-12-28 | Biogen, Inc. | DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides |
US4530901A (en) * | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
DE3176404D1 (en) * | 1980-04-22 | 1987-10-08 | Pasteur Institut | Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine |
US4393133A (en) * | 1980-06-12 | 1983-07-12 | The Wistar Institute Of Anatomy And Biology | Human hepatoma derived cell line, process for preparation thereof, and uses therefor |
US5145782A (en) * | 1980-12-08 | 1992-09-08 | The Regents Of The University Of California | DNA expression vector suitable for direct expression of a foreign gene |
US4446237A (en) * | 1981-03-27 | 1984-05-01 | Life Technologies, Inc. | Method for detection of a suspect viral deoxyribonucleic acid in an acellular biological fluid |
EP0062286A1 (en) * | 1981-03-31 | 1982-10-13 | Albert Einstein College Of Medicine Of Yeshiva University | Diagnostic test for hepatitis B virus |
US4711955A (en) * | 1981-04-17 | 1987-12-08 | Yale University | Modified nucleotides and methods of preparing and using same |
US4769238A (en) | 1981-08-04 | 1988-09-06 | The Regents Of The University Of California | Synthesis of human virus antigens by yeast |
ZW18282A1 (en) | 1981-08-31 | 1983-03-23 | Genentech Inc | Preparation of polypeptides in vertebrate cell culture |
US4803164A (en) * | 1981-08-31 | 1989-02-07 | Genentech, Inc. | Preparation of hepatitis b surface antigen in yeast |
AU8746582A (en) * | 1981-09-02 | 1983-03-10 | Biogen N.V. | Hepatitis b virus e type antigen |
FI63596C (en) * | 1981-10-16 | 1983-07-11 | Orion Yhtymae Oy | MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER |
US4480040A (en) * | 1981-12-03 | 1984-10-30 | The United States Of America As Represented By The Secretary Of Agriculture | Sensitive and rapid diagnosis of viroid diseases and viruses |
JPS5931799A (en) * | 1982-08-16 | 1984-02-20 | Science & Tech Agency | Recombinant plasmid and preparation of transformed yeast and hepatitis virus b surface antigen using the same |
USRE35491E (en) * | 1982-11-04 | 1997-04-08 | The Regents Of The University Of California | Methods and compositions for detecting human tumors |
US4699877A (en) * | 1982-11-04 | 1987-10-13 | The Regents Of The University Of California | Methods and compositions for detecting human tumors |
US4820642A (en) * | 1983-04-04 | 1989-04-11 | The Regents Of The University Of California | Amplified expression vector |
FR2560995B1 (en) * | 1984-03-07 | 1988-02-19 | Pasteur Institut | REAGENTS AND KITS FOR THE QUANTITATIVE DETERMINATION OF A VIRAL NUCLEIC ACID IN A BIOLOGICAL MEDIUM AND METHOD FOR DETERMINING SUCH A VIRAL NUCLEIC ACID |
US5780036A (en) * | 1991-08-26 | 1998-07-14 | The Scripps Research Institute | Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus |
US6607727B1 (en) | 1991-08-26 | 2003-08-19 | The Scripps Research Institute | Peptides for inducing cytotoxic T lymphocyte responses to hepatitus B virus |
DE69231693T2 (en) * | 1991-12-23 | 2001-05-31 | Bayer Ag | HBV AMPLIFICATION PROBE FOR USE IN HYBRIDIZATION SANDWICH ASSAY IN THE SOLUTION PHASE |
US6235288B1 (en) | 1992-08-26 | 2001-05-22 | The Scripps Research Institute | Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
JP2003502033A (en) | 1999-06-16 | 2003-01-21 | アイコス コーポレイション | Human poly (ADP-ribose) polyamylase 2 materials and methods |
US7405276B2 (en) | 2000-11-01 | 2008-07-29 | Elusys Therapeutics, Inc. | Method of producing bispecific molecules by protein trans-splicing |
CA2605701C (en) | 2005-04-29 | 2015-12-08 | Rockefeller University | Human micrornas and methods for inhibiting same |
EP1928492B1 (en) | 2005-09-01 | 2011-02-23 | Celgene Corporation | Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy |
JP2010531878A (en) | 2007-06-27 | 2010-09-30 | マリン ポリマー テクノロジーズ,インコーポレーテッド | Complex of IL-15 and IL-15Rα and use thereof |
EP2324044A4 (en) | 2008-08-04 | 2012-04-25 | Univ Miami | Sting (stimulator of interferon genes), a regulator of innate immune responses |
US8691502B2 (en) | 2008-10-31 | 2014-04-08 | Tremrx, Inc. | T-cell vaccination with viral vectors via mechanical epidermal disruption |
WO2010085660A2 (en) | 2009-01-23 | 2010-07-29 | Roger Williams Hospital | Viral vectors encoding multiple highly homologous non-viral polypeptides and the use of same |
WO2011091435A2 (en) | 2010-01-25 | 2011-07-28 | Mount Sinai School Of Medicine | Methods of treating liver disease |
WO2012151272A2 (en) | 2011-05-02 | 2012-11-08 | Tremrx, Inc. | T-cell vaccination with viral vectors via mechanical epidermal disruption |
CA2863600A1 (en) | 2012-02-16 | 2013-08-22 | The Penn State Research Foundation | Modulators of acyl-coa lysocardiolipin acyltransferase 1 ( alcat1) and uses thereof |
WO2014066527A2 (en) | 2012-10-24 | 2014-05-01 | Admune Therapeutics Llc | Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes |
WO2016018920A1 (en) | 2014-07-29 | 2016-02-04 | Admune Therapeutics Llc | Il-15 and il-15ralpha heterodimer dose escalation regimens for treating conditions |
US11370823B2 (en) | 2014-10-29 | 2022-06-28 | Massachusetts Eye And Ear Infirmary | Efficient delivery of therapeutic molecules to cells of the inner ear |
WO2016069912A1 (en) | 2014-10-29 | 2016-05-06 | Massachusetts Eye And Ear Infirmary | Efficient delivery of therapeutic molecules in vitro and in vivo |
US20220118077A1 (en) | 2018-09-11 | 2022-04-21 | Shanghai Public Health Clinical Center | Immunogen for broad-spectrum influenza vaccine and application thereof |
US11786592B2 (en) | 2021-05-19 | 2023-10-17 | The University Of Hong Kong | Compositions of cardiolipin adjuvants and methods of use thereof |
WO2023077147A2 (en) | 2021-11-01 | 2023-05-04 | Pellis Therapeutics, Inc. | T-cell vaccines for patients with reduced humoral immunity |
WO2023220283A1 (en) | 2022-05-12 | 2023-11-16 | Pellis Therapeutics, Inc. | Poxvirus adjuvant for t-cell vaccination |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1521032A (en) * | 1974-08-08 | 1978-08-09 | Ici Ltd | Biological treatment |
DE2712615A1 (en) * | 1977-03-18 | 1978-09-21 | Max Planck Gesellschaft | PROCESS FOR MANUFACTURING FILAMENTOES PHAGEN AS A VECTOR FOR SYNTHETIC RECOMBINATES |
-
1978
- 1978-12-18 FR FR7835588A patent/FR2444713A1/en active Granted
-
1979
- 1979-12-12 CH CH1099879A patent/CH646456A5/en not_active IP Right Cessation
- 1979-12-18 BE BE2/58277A patent/BE880670A/en not_active IP Right Cessation
- 1979-12-18 GB GB7943491A patent/GB2034323B/en not_active Expired
- 1979-12-18 OA OA56977A patent/OA06416A/en unknown
- 1979-12-18 DE DE19792950995 patent/DE2950995A1/en active Granted
Also Published As
Publication number | Publication date |
---|---|
DE2950995C2 (en) | 1991-05-02 |
CH646456A5 (en) | 1984-11-30 |
FR2444713A1 (en) | 1980-07-18 |
BE880670A (en) | 1980-06-18 |
GB2034323B (en) | 1983-01-12 |
FR2444713B1 (en) | 1981-02-06 |
GB2034323A (en) | 1980-06-04 |
DE2950995A1 (en) | 1980-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA06416A (en) | A method of producing a DNA comprising the genome of the hepatitis B virus and a vector comprising it. | |
GB2070621B (en) | Nucleotidic sequence coding the surface antigen of the hepatitis b virus vector containing said nucleotidic sequence process allowing the obtention thereof and antigen obtained thereby | |
YU140380A (en) | Process for obtaining dna fragment of hepatitis b virus | |
IT8267522A0 (en) | PROCESS FOR THE PRODUCTION OF COMPLEMENTARY DNA REPRESENTING VIRAL RNA SEQUENCES BY RECOMBINANT DNA METHODS RELATED PRODUCTS AND THEIR USES | |
IT7920867A0 (en) | PROCESS FOR THE PRODUCTION OF OXYGEN GAS PERCEPTORS. | |
ES449670A1 (en) | Method of removal of hepatitis virus | |
KR870007282A (en) | Method for producing hepatitis B virus protein from yeast | |
NL7903927A (en) | VINYL TILE AND PROCESS FOR ITS MANUFACTURE. | |
BE827439A (en) | PROCESS FOR THE CATALYTIC OBTAINING OF PYRIDINES FROM ALCYNES AND NITRILS | |
OA06823A (en) | Stainless steel production process. | |
OA06920A (en) | Spiro-quartenary ammonium halides, their preparation process and their use in a process for the production of N- (2-pyrimidinyl) piperazinyl-alkylazospiro-alkanédiones. | |
RO72609A (en) | PROCESS FOR THE PREPARATION OF 1-ARYL-2- (1-IM-DIAZOM) -ALCHILE ETHYLS AND THIETHERS | |
PT73021A (en) | Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens | |
EP0182442A3 (en) | Recombinant DNA molecules and their method of production. | |
ATA147379A (en) | VINYL HALOGENIDE POLYMERIZATION PROCESS | |
JPS5550892A (en) | Protein production * modified dna and vector applicable to said method | |
IT8141656A0 (en) | INDUSTRIAL PROCESS FOR THE PRODUCTION OF TUBULAR JACQUARD FABRICS AND THE PRODUCT OBTAINED SO. | |
GB2079288B (en) | Dna sequences recombinat dna molecules and processes for producing polypeptides with the specificity of foot and mouth disease viral antigens | |
OA05568A (en) | Chemical process for isotopic enrichment of uranium. | |
NL7903866A (en) | HEAT-INSULATED PIPE AND PROCESS FOR ITS MANUFACTURE. | |
AT387392B (en) | METHOD FOR PRODUCING 1ALPHA, 3BETADIHYDROXY-DELTA 5 STEROIDS | |
FR2606281B1 (en) | HEPATITIS B VIRUS ANTIGEN AND METHOD FOR THE PRODUCTION THEREOF | |
FR2464269B1 (en) | NUCLEOTIDE SEQUENCE ENCODING HEPATITIS B VIRUS SURFACE ANTIGEN, PROCESS FOR OBTAINING SAME AND ANTIGEN OBTAINED | |
MX5789E (en) | IMPROVED SUSPENSION POLYMERIZATION PROCESS | |
EP0119259A4 (en) | Non a, non b hepatitis virus, methods of identification, purification, characterization, diagnosis and immunization. |